Oscar Health (OSCR) Stock Price, News & Analysis

Company Overview

Oscar Health, Inc. is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams. Plan availability, benefits and provider networks vary by state and market.

Founded in 2012 by Mario Schlosser, Kevin Nazemi and Joshua Kushner, Oscar Health is headquartered in New York City. The company became publicly traded on the New York Stock Exchange in 2021 under the symbol OSCR. Mark Bertolini serves as Oscar Health’s chief executive officer.

Key Stats

• Today's Range: $31.88 to $34.12
• 50-Day Range: $26.53 to $33.86
• 52-Week Range: $10.69 to $34.48
• Volume: 5.59 million shs
• Average Volume: 4.63 million shs
• Market Capitalization: $9.87 billion
• P/E Ratio: 22.83
• Dividend Yield: N/A
• Price Target: $31.50
• Consensus Rating: Hold

Oscar Health Stock Analysis - MarketRank™

Oscar Health scored higher than 80% of companies evaluated by MarketBeat, and ranked 105th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Hold

Consensus Rating

Oscar Health has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 1 strong buy rating, 3 buy ratings, 8 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Oscar Health is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Oscar Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 16.23%

Earnings Growth

Earnings for Oscar Health are expected to grow by 16.23% in the coming year, from $1.54 to $1.79 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Oscar Health is 22.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.68.

Price to Earnings Ratio vs. Sector

The P/E ratio of Oscar Health is 22.83, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.27.

Price to Earnings Growth Ratio

Oscar Health has a PEG Ratio of 0.47. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Oscar Health has a P/B Ratio of 9.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

6.85% of the float of Oscar Health has been sold short.

Short Interest Ratio / Days to Cover

Oscar Health has a short interest ratio ("days to cover") of 3.47, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Oscar Health has recently decreased by 0.45%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Oscar Health does not currently pay a dividend.

Dividend Growth

Oscar Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.55

News Sentiment

Oscar Health has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 18 news articles for Oscar Health this week, compared to 6 articles on an average week.

Search Interest

Only 12 people have searched for OSCR on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.

MarketBeat Follows

13 people have added Oscar Health to their MarketBeat watchlist in the last 30 days. This is an increase of 117% compared to the previous 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Oscar Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $126,818,346.00 in company stock.

Percentage Held by Insiders

22.64% of the stock of Oscar Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

75.70% of the stock of Oscar Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/17/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Managed Healthcare
• Current Symbol: NYSE:OSCR
• CIK: 1568651
• Web: www.hioscar.com
• Phone: 646-403-3677
• Fax: N/A
• Employees: 2,305
• Year Founded: 2012

Price Target and Rating

• Average Price Target for Oscar Health: $31.50
• High Price Target: $49.00
• Low Price Target: $16.00
• Potential Upside/Downside: -1.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.31
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.40
• Trailing P/E Ratio: 22.83
• Forward P/E Ratio: 20.76
• P/E Growth: 0.47
• Net Income: -$443.15 million
• Net Margins: 3.60%
• Pretax Margin: 3.85%
• Return on Equity: 38.45%
• Return on Assets: 6.76%

Debt

• Debt-to-Equity Ratio: 0.21
• Current Ratio: 1.09
• Quick Ratio: 1.09

Sales & Book Value

• Annual Sales: $11.70 billion
• Price / Sales: 0.84
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.29 per share
• Price / Book: 9.72

Miscellaneous

• Outstanding Shares: 308,640,000
• Free Float: 238,768,000
• Market Cap: $9.87 billion
• Optionable: Optionable
• Beta: 2.37